Safety of nanomedicines: Reality check?

Tuesday 15th of April 2014
SY22, 1.5 hours

Chair: Gert Fricker (Germany)

Meeting room 210

13.00 – 13.30     The value of not over-engineering – simple biocompatible nanoconstructs overcome MGST-1 mediated resistance in breast cancer
(TU-18-01) Andreas Nystrom, Karolinska Institute, Sweden

13.30 – 14.00     Immunological properties of engineered nanomaterials and challenges with preclinical development of nanomedicines
(TU-18-02) Marina Dobrovolskaia, SAIC Frederick, Inc., Frederick, USA

14.00 – 14.30     Nanoparticles and skin: unmoveable objects and irresistible barrier
(TU-18-02) Richard Guy, University of Bath, UK